Geode Capital Management
PRME icon

Geode Capital Management’s Prime Medicine PRME Stock Holding History

Geode Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Sell
2,712,446
-31,254
-1% -$104K ﹤0.01% 2547
2026
Q1 		$9.55M Buy
2,743,700
+115,271
+4% +$439K ﹤0.01% 2405
2025
Q4 		$9.12M Buy
2,628,429
+861,533
+49% +$3.83M ﹤0.01% 2455
2025
Q3 		$9.79M Buy
1,766,896
+256,147
+17% +$1.04M ﹤0.01% 2426
2025
Q2 		$3.73M Sell
1,510,749
-15,781
-1% -$24.3K ﹤0.01% 2880
2025
Q1 		$3.04M Buy
1,526,530
+58,924
+4% +$150K ﹤0.01% 2882
2024
Q4 		$4.29M Buy
1,467,606
+107,627
+8% +$378K ﹤0.01% 2813
2024
Q3 		$5.26M Buy
1,359,979
+63,456
+5% +$294K ﹤0.01% 2734
2024
Q2 		$6.67M Buy
1,296,523
+379,662
+41% +$2.3M ﹤0.01% 2573
2024
Q1 		$6.42M Buy
916,861
+29,358
+3% +$223K ﹤0.01% 2564
2023
Q4 		$7.86M Buy
887,503
+40,866
+5% +$315K ﹤0.01% 2466
2023
Q3 		$8.08M Buy
846,637
+306,329
+57% +$3.98M ﹤0.01% 2389
2023
Q2 		$7.92M Buy
540,308
+299,963
+125% +$4.19M ﹤0.01% 2432
2023
Q1 		$2.96M Buy
240,345
+6,050
+3% +$98.6K ﹤0.01% 2865
2022
Q4 		$4.35M Buy
+234,295
New +$4.23M ﹤0.01% 2739

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Geode Capital Management's PRME Position: Q2 2026 in Review

Geode Capital Management reduced its Prime Medicine (PRME) stake by 1.1% in Q2 2026, selling an estimated $104K and leaving 2,712,446 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

Geode Capital Management first reported a position in PRME in Q4 2022 and has held it in 15 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Geode Capital Management held 2,712,446 shares of Prime Medicine worth $10M as of Q2 2026.
  • Geode Capital Management sold 31,254 Prime Medicine shares in Q2 2026, an estimated $104K.
  • Prime Medicine made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2547 holding.
  • Geode Capital Management first reported a position in Prime Medicine in Q4 2022 and has held it in 15 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.